ArticlePharmaceuticals (Basel, Switzerland)2026

Rebamipide Reprograms Hepatic Networks to Prevent and Reverse Metabolic-Dysfunction-Associated Steatotic Liver Disease: Multi-Omics Insights and Histological Validation.

Hebatallah H Abo Nahas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.